Table 1 Baseline characteristic of population.

From: Pregnancy outcomes of endometrial hyperplasia with or without atypia

 

Non-EH group (n=197,488)

EH group (n=1655)

p-value

Age, mean (SD)

31.74±3.79

34.45±3.85

< 0.001

≤ 25 years, n (%)

3633 (1.84)

3 (0.18)

< 0.001

25–30 years, n (%)

52,939 (26.81)

143 (8.64)

 

30–34 years, n (%)

97,976 (49.61)

713 (43.08)

 

35–39 years, n (%)

36,738 (18.60)

614 (37.1)

 

≥ 40 years, n (%)

6202 (3.14)

182 (11.0)

 

BMI kg/m2 at delivery

mean (SD)

21.97±3.48

23.02±4.15

0.009

<18.5 kg/m2, n (%)

21,807 (11.04)

152 (9.18)

< 0.001

18.5–23 kg/m2, n (%)

115,184 (58.32)

873 (52.75)

 

23–25 kg/m2, n (%)

28,082 (14.22)

229 (13.84)

 

25–30 kg/m2, n (%)

26,020 (13.18)

264 (15.95)

 

≥ 30 kg/m2, n (%)

6396 (3.24)

137 (8.28)

 

PCOS, n (%)

54,150 (27.42)

954 (57.64)

< 0.001

Hypertension, n (%)

5483 (2.78)

152 (9.18)

< 0.001

Diabetes, n (%)

12,598 (6.38)

341 (20.6)

< 0.001

Hyperthyroidism, n (%)

12,984 (6.57)

215 (12.99)

< 0.001

Hypothyroidism, n (%)

19,868 (10.06)

482 (29.12)

< 0.001

Autoimmune disease, n (%)

2777 (1.41)

51 (3.08)

< 0.001

Previous uterine surgery

46383 (22.47)

633 (61.94)

< 0.001

  1. Abbreviation: EH, endometrial hyperplasia; BMI, body mass index; PCOS, polycystic ovarian syndrome.